Advancing the realization of oral insulin using novel peptide technology

For more than a century, oral insulin has been considered a “dream” therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport mechanism. Consequently, many patients must rely on daily insulin injections, which can significantly reduce their quality of life.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup